The U.S. Food and Drug Administration has cleared the removal of the imaging contraindication, making Abbott’s systems the first and only patient-applied CGM sensors approved for these screenings.

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Abbott said it makes its systems the first and only patient-applied CGM sensors approved for these screenings. Users no longer have to remove and discard the sensor for these imaging procedures before ...

In an interview with The New Indian Express, Dr Robert Floyd, Executive Secretary of the CTBTO, shared insights into how scientific data was used to dispel these rumours. He also discussed the ...

Fortunately, new technology innovations are helping to improve their safety. Todd Connelly, Rental Sales Manager for Blackline Safety, joins the podcast to discuss why confined space entries ...

Previous sensors were limited to measuring either static or dynamic forces; however, this research team has pioneered a technology that can separate and analyze these forces simultaneously. Notably, ...

The global injection pen market is poised for significant growth, with projections indicating a robust compound annual growth rate (CAGR) of 7.0% from 2022 to 2033. The market is expected to escalate ...

The new software is an upgrade ... who want to see iLet pump and CGM data regardless of whether they're using an iPhone or Android device. The free app can be downloaded from the Apple App store or ...

Their BGLs were measured using the smartwatch and a commercial continuous glucose monitoring sensor, the latter of which was used to capture the reference values. Notably, preprocessing the data ...

While hardware revenue is continuing to decline - 58% to $42.4 million in Q3/24 - revenue for sensor ... Medtronic that it is providing both components - the insulin pump as well as the CGM ...